Naturex SA   Report issue

For profit Phase 2
Founded: Avignon France (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2008
NCT00981981
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

CreaNutrition, AG | Naturex | Naturex-Dbs | Naturex SA | NATURIEX-DBS,, LLC

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Diseases, Metabolic (Phase 2)

Hypercholesterolemia (Phase 2)

Lower Urinary Tract Symptoms (Phase 2)

Urinary Bladder, Overactive (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 27
  • # of Trial APIs: 18